atrasentan has been researched along with cgs 35066 in 1 studies
| Studies (atrasentan) | Trials (atrasentan) | Recent Studies (post-2010) (atrasentan) | Studies (cgs 35066) | Trials (cgs 35066) | Recent Studies (post-2010) (cgs 35066) |
|---|---|---|---|---|---|
| 358 | 41 | 108 | 18 | 0 | 1 |
| Protein | Taxonomy | atrasentan (IC50) | cgs 35066 (IC50) |
|---|---|---|---|
| Neprilysin | Rattus norvegicus (Norway rat) | 2.3 | |
| Neprilysin | Oryctolagus cuniculus (rabbit) | 2.3 | |
| Neprilysin | Homo sapiens (human) | 2.3 | |
| Angiotensin-converting enzyme | Homo sapiens (human) | 1.161 | |
| Endothelin-converting enzyme 1 | Homo sapiens (human) | 0.022 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayach, B; Battistini, B; Blouin, A; Cernacek, P; Jeng, AY; Opgenorth, T; Tsang, J; Verreault, M; Wessale, J | 1 |
1 other study(ies) available for atrasentan and cgs 35066
| Article | Year |
|---|---|
Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model.
Topics: Acute Disease; Animals; Aspartic Acid Endopeptidases; Atrasentan; Benzofurans; Cardiovascular Agents; Disease Models, Animal; Embolism, Air; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-Converting Enzymes; Endothelins; Hemodynamics; Hypertension, Pulmonary; Male; Metalloendopeptidases; Organophosphonates; Protease Inhibitors; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides; Time Factors; Ventricular Dysfunction, Right | 2004 |